Enriched Pharmacokinetic Behavior and Antitumor Efficacy of Thymoquinone by Liposomal DeliveryHari Krishnareddy Rachamalla, Rintu Banerjee, Basit L. Jan et al.|Nanomedicine|2021Cited by 7
Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemiaVijay Sagar Madamsetty, Asher Chanan‐Khan, Aneel Paulus et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 6
Importance of Surface-modified Nanocarriers in the Management of Cervical CancerHari Krishnareddy Rachamalla, Vijay Sagar Madamsetty|BENTHAM SCIENCE PUBLISHERS eBooks|2023Cited by 0
Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiformeDebabrata Mukhopadhyay, Alfredo Quiñones‐Hinojosa, Ramcharan Singh Angom et al.|Research Square|2025Cited by 0